Oral dryness and peripheral neuropathy in subjects with type 2 diabetes

Journal of Diabetes and its Complications

Volumn 17, Issue 4, 2003, Pages 192-198

  Sandberg, Gun E ^a,b   Wikblad, Karin F ^b,c  

^a DALARNA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Peripheral neuropathy; Type 2 diabetes; Xerostomia

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; FEMALE; FOOT; HEALTH CARE SYSTEM; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZATION; REGRESSION ANALYSIS; SCORING SYSTEM; SYMPTOM; XEROSTOMIA;

EID: 0142029441     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(02)00220-9     Document Type: Article

References (53)

1. Anderson L.C., Shapiro B.L. The effect of alloxan diabetes and insulin in vivo on peroxidase activity in the rat submandibular gland. Archives of Oral Biology. 24:1979;343-345.
2. Apelqvist J. The diabetic foot (Den diabetiska foten). 1996;Pharmacia, Stockholm.
3. Ben-Aryeh H., Cohen M., Kanter Y., Szargel R., Laufer D. Salivary composition in diabetic patients. Journal of Diabetes and its Complications. 2:1988;96-99.
4. Ben-Aryeh H., Serouya R., Kanter Y., Szargel R., Laufer D. Oral health and salivary composition in diabetic patients. Journal of Diabetes and its Complications. 7:1993;57-62.
5. Brismar K. The diabetic foot, medical foot record (Den diabetiska foten, fotjournal). 1997;Department of Endocrinology and Diabetology, Karolinska sjukhuset, Stockholm.
6. Chang C., Lu F., Yang Y.C., Wu J.S., Wu T.J., Chen M.S.et al. Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Research and Clinical Practice. 50(Suppl. 2):2000;S49-S59.
7. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. Journal of Dental Research. 66:1987;648-653.
8. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes. 37:1988;476-481.
9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine. 329:1993;977-986.
10. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 41:1998;416-423.
11. Dyck P.J. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle & Nerve. 11(1):1988;21-32.
12. Emmelin N., Gjorstrup P. Interaction between sympathetic and parasympathetic salivary nerves in anaesthetized dogs. Archives of Oral Biology. 21:1976;27-32.
13. Epstein J.B., Scully C. The role of saliva in oral health and the causes and effects of xerostomia. Journal of the Canadian Dental Association. 58:1992;217-221.
14. Flynn M.D., O'Brien I.A., Corrall R.J. The prevalence of autonomic and peripheral neuropathy in insulin-treated diabetic subjects. Diabetic Medicine. 12:1995;310-313.
15. Fox P.C., van der Ven P.F., Sonies B.C., Weiffenbach J.M., Baum B.J. Xerostomia: evaluation of a symptom with increasing significance. Journal of the American Dental Association. 110:1985;519-525.
16. Franklin G.M., Shetterly S.M., Cohen J.A., Baxter J., Hamman R.F. Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care. 17:1994;1172-1177.
17. Giachetti A. The functional state of sympathetic nerves in spontaneously diabetic mice. Diabetes. 27:1978;969-974.
18. Gilbert G.H., Heft M.W., Duncan R.P. Mouth dryness as reported by older Floridians. Community Dentistry and Oral Epidemiology. 21:1993;390-397.
19. Grant I.A., Hunder G.G., Homburger H.A., Dyck P.J. Peripheral neuropathy associated with sicca complex. Neurology. 48:1997;855-862.
20. Greene D.A., Stevens M.J., Feldman E.L. Diabetic neuropathy: scope of the syndrome. American Journal of Medicine. 107:1999;2S-8S.
21. Griffin J.W., Cornblath D.R., Alexander E., Campbell J., Low P.A., Bird S.et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Annals of Neurology. 27:1990;304-315.
22. Herrera J.L., Lyons M.F. Jr., Johnson L.F. Saliva: its role in health and disease. Journal of Clinical Gastroenterology. 10:1988;569-578.
23. Jirkovska A., Boucek P., Woskova V., Bartos V., Skibova J. Identification of patients at risk for diabetic foot: a comparison of standardized noninvasive testing with routine practice at community diabetes clinics. Journal of Diabetes and its Complications. 15:2001;63-68.
24. Kaplan J.G., Rosenberg R., Reinitz E., Buchbinder S., Schaumburg H.H. Invited review: peripheral neuropathy in Sjogren's syndrome. Muscle & Nerve. 13:1990;570-579.
25. Kuroda N., Taniguchi H., Baba S., Yamamoto M. Relationship between age and autonomic neuropathy in diabetes mellitus. Diabetes Research and Clinical Practice. 9:1990;49-53.
26. Lipkin E. New strategies for the treatment of type 2 diabetes. Journal of the American Dietetic Association. 99:1999;329-334.
27. Lluch I., Hernandez A., Real J.T., Morillas C., Tenes S., Sanchez C.et al. Cardiovascular autonomic neuropathy in type 1 diabetic patients with and without peripheral neuropathy. Diabetes Research and Clinical Practice. 42:1998;35-40.
28. Mandl T., Jacobsson L., Lilja B., Sundkvist G., Manthorpe R. Disturbances of autonomic nervous function in primary Sjogren's syndrome. Scandinavian Journal of Rheumatology. 26:1997;253-258.
29. Melton L., Dyck P. Diabetic polyneuropathy. Dyck P., Thomas P. Diabetic neuropathy. 2nd ed. 1999;239-254 WB Saunders, Philadelphia.
30. Melvin J.E. Saliva and dental diseases. Current Opinion in Dentistry. 1:1991;795-801.
31. Partanen J., Niskanen L., Lehtinen J., Mervaala E., Siitonen O., Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. New England Journal of Medicine. 333:1995;89-94.
32. Pirart J., Lauvaux J.P., Rey W. Blood sugar and diabetic complications. New England Journal of Medicine. 298:1978;1149.
33. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197.
34. Sandberg G.E., Sundberg H.E., Fjellstrom C.A., Wikblad K.F. Type 2 diabetes and oral health. A comparison between diabetic and non-diabetic subjects. Diabetes Research and Clinical Practice. 50:2000;27-34.
35. Sandberg G.E., Sundberg H.E., Wikblad K.F. A controlled study of oral self-care and self-perceived oral health in type 2 diabetic patients. Acta Odontologica Scandinavica. 59:2001;28-33.
36. Sas R., Dawes C. The intra-oral distribution of unstimulated and chewing-gum-stimulated parotid saliva. Archives of Oral Biology. 42:1997;469-474.
37. Shaw J.E., Hodge A.M., de Courten M., Dowse G.K., Gareeboo H., Tuomilehto J.et al. Diabetic neuropathy in Mauritius: prevalence and risk factors. Diabetes Research and Clinical Practice. 42:1998;131-139.
38. Sima A.A., Cherian P.V. Neuropathology of diabetic neuropathy and its correlations with neurophysiology. Clinical Neuroscience. 4:1997;359-364.
39. Sreebny L.M., Valdini A. Xerostomia. A neglected symptom. Archives of Internal Medicine. 147:1987;1333-1337.
40. Stefaniotis T.D., Donta C.N. Incidence of xerostomia in patients with drug-controlled diabetes mellitus. Hellenic Stomatological Review. 34:1990;97-101.
41. Summerson J.H., Spangler J.G., Bell R.A., Shelton B.J., Konen J.C. Association of gender with symptoms and complications in type II diabetes mellitus. Women's Health Issues. 9:1999;176-182.
42. Tenovuo J. Salivary parameters of relevance for assessing caries activity in individuals and populations. Community Dentistry and Oral Epidemiology. 25:1997;82-86.
43. Tesfaye S., Stevens L.K., Stephenson J.M., Fuller J.H., Plater M., Ionescu-Tirgoviste C.et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 11:1996;1377-1384.
44. Uhrbom, E., & Bjerner, B. (1998). EPIWUX 98. Department of Public Health, County of Dalarna (Report no. 70).
45. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 352:1998;837-853.
46. Veves A., Uccioli L., Manes C., Van Acker K., Komninou H., Philippides P.et al. Comparison of risk factors for foot problems in diabetic patients attending teaching hospital outpatient clinics in four different European states. Diabetic Medicine. 11:1994;709-713.
47. Watkins P.J. Diabetic nephropathy: prevalence, complications and treatment. Diabetic Medicine. 2:1985;7-12.
48. WHO, 1999. Diabetes mellitus. Fact sheet. Geneva: WHO/OMS, 2000, (Information, Report no. 138).
49. Wikblad K., Smide B., Bergstrom A., Kessi J., Mugusi F. Outcome of clinical foot examination in relation to self-perceived health and glycaemic control in a group of urban Tanzanian diabetic patients. Diabetes Research and Clinical Practice. 37:1997;185-192.
50. Wright R.A., Grant I.A., Low P.A. Autonomic neuropathy associated with sicca complex. Journal of the Autonomic Nervous System. 75:1999;70-76.
51. Young M., Boulton A., Macleod A., Williams D., Sonksen P. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 36:1993;150-154.
52. Zachariasen, R. D. (1992). Diabetes mellitus and xerostomia. Compendium, 13, 314, 316, 318-322 passim.
53. Zachariasen R.D. Xerostomia and the diabetic patient. Journal of the Greater Houston Dental Society. 67:1996;10-13.